Literature DB >> 25786387

Diagnosis of Cushing's disease.

Eleni Daniel1, John D C Newell-Price.   

Abstract

Diagnosis of Cushing's disease frequently remains a challenge. In this review we critically appraise the clinical features, biochemical tests, and imaging modalities used for this purpose. We outline recommendations for approaches to clinical investigation, with a particular focus on developments made within the last two years.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25786387     DOI： 10.1007/s11102-015-0649-2

Source DB:  PubMed          Journal:  Pituitary        ISSN： 1386-341X            Impact factor:   4.107


  34 in total

1.  Identification of patients with Cushing's disease with negative pituitary adrenocorticotropin gradients during inferior petrosal sinus sampling: prolactin as an index of pituitary venous effluent.

Authors:  James W Findling; Michael E Kehoe; Hershel Raff
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

Review 2.  Is prolactin measurement of value during inferior petrosal sinus sampling in patients with adrenocorticotropic hormone-dependent Cushing's Syndrome?

Authors:  S T Sharma; L K Nieman
Journal:  J Endocrinol Invest       Date:  2013-07-26       Impact factor: 4.256

Review 3.  The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states.

Authors:  J Newell-Price; P Trainer; M Besser; A Grossman
Journal:  Endocr Rev       Date:  1998-10       Impact factor: 19.871

4.  Utility of hCRH-stimulated (18) F-FDG PET-CT scan in localisation of pituitary microadenoma in Cushing's disease.

Authors:  H P Patt; V Lele; A Lila; T Bandgar; N Shah
Journal:  J Med Imaging Radiat Oncol       Date:  2014-04       Impact factor: 1.735

5.  Feasibility of high-resolution pituitary MRI at 7.0 tesla.

Authors:  Alexandra A J de Rotte; Anja G van der Kolk; Dik Rutgers; Pierre M J Zelissen; Fredy Visser; Peter R Luijten; Jeroen Hendrikse
Journal:  Eur Radiol       Date:  2014-05-29       Impact factor: 5.315

6.  High-resolution MR imaging of pituitary microadenomas at 1.5 T: experience with Cushing disease.

Authors:  W W Peck; W P Dillon; D Norman; T H Newton; C B Wilson
Journal:  AJR Am J Roentgenol       Date:  1989-01       Impact factor: 3.959

7.  Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors.

Authors:  Marina S Zemskova; Bhaskar Gundabolu; Ninet Sinaii; Clara C Chen; Jorge A Carrasquillo; Millie Whatley; Iffat Chowdhury; Ahmed M Gharib; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2010-01-20       Impact factor: 5.958

8.  The accuracy of CT and MR evaluation of the sella turcica for detection of adrenocorticotropic hormone-secreting adenomas in Cushing disease.

Authors:  M Buchfelder; R Nistor; R Fahlbusch; W J Huk
Journal:  AJNR Am J Neuroradiol       Date:  1993 Sep-Oct       Impact factor: 3.825

9.  Clinical utility of plasma POMC and AgRP measurements in the differential diagnosis of ACTH-dependent Cushing's syndrome.

Authors:  Gabrielle Page-Wilson; Pamela U Freda; Thomas P Jacobs; Alexander G Khandji; Jeffrey N Bruce; Sandra T Foo; Kana Meece; Anne White; Sharon L Wardlaw
Journal:  J Clin Endocrinol Metab       Date:  2014-07-11       Impact factor: 5.958

10.  Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours.

Authors:  I Buchmann; M Henze; S Engelbrecht; M Eisenhut; A Runz; M Schäfer; T Schilling; S Haufe; T Herrmann; U Haberkorn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-23       Impact factor: 9.236
View more
  4 in total

1.  Rapidly progressive ACTH-dependent Cushing's disease masquerading as ectopic ACTH-producing Cushing's syndrome: illustrative case.

Authors:  Siyuan Yu; Michael Karsy; Jeffrey Miller; Stephanie R Beldick; Mark T Curtis; Marc Rosen; James J Evans
Journal:  J Neurosurg Case Lessons       Date:  2021-07-05

2.  ACTH-dependent Cushing's Syndrome: Diagnostic Pitfalls in Concomitant Non-secreting Pituitary Adenomas.

Authors:  Pietro Lucotti; Cesare Zoia; Elisabetta Lovati; Paolo Gaetani; Gino R Corazza
Journal:  Eur J Case Rep Intern Med       Date:  2016-03-30

3.  The Role of Isotretinoin Therapy for Cushing's Disease: Results of a Prospective Study.

Authors:  Lucio Vilar; José Luciano Albuquerque; Ruy Lyra; Erik Trovão Diniz; Frederico Rangel Filho; Patrícia Gadelha; Ana Carolina Thé; George Robson Ibiapina; Barbara Sales Gomes; Vera Santos; Maíra Melo da Fonseca; Karoline Frasão Viana; Isis Gabriella Lopes; Douglas Araújo; Luciana Naves
Journal:  Int J Endocrinol       Date:  2016-02-29       Impact factor: 3.257

4.  Indication to dynamic and invasive testing in Cushing's disease according to different neuroradiological findings.

Authors:  E Ferrante; M Barbot; A L Serban; F Ceccato; G Carosi; L Lizzul; E Sala; A Daniele; R Indirli; M Cuman; M Locatelli; R Manara; M Arosio; M Boscaro; G Mantovani; C Scaroni
Journal:  J Endocrinol Invest       Date:  2021-10-26       Impact factor: 4.256
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.